Banco Bilbao Vizcaya Argentaria’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	106,595 +64,928	+156%	+$8.11M	0.09%	154
2025 Q4	$5.09M	Buy	+41,667	New	+$4.78M	0.04%	289
2025 Q3	–	Sell	-38,072	Closed	-$3.17M	–	747
2025 Q2	$3.17M	Sell	38,072 -18,775	-33%	-$1.5M	0.03%	334
2025 Q1	$4.58M	Buy	56,847 +16,482	+41%	+$1.47M	0.05%	270
2024 Q4	$3.62M	Sell	40,365 -36,112	-47%	-$3.5M	0.04%	316
2024 Q3	$7.56M	Buy	76,477 +14,301	+23%	+$1.41M	0.08%	222
2024 Q2	$5.75M	Buy	62,176 +6,735	+12%	+$604K	0.06%	247
2024 Q1	$5.26M	Sell	55,441 -22,142	-29%	-$2.05M	0.06%	259
2023 Q4	$6.96M	Sell	77,583 -33,112	-30%	-$2.46M	0.08%	228
2023 Q3	$8.09M	Sell	110,695 -31,025	-22%	-$2.48M	0.11%	197
2023 Q2	$11.8M	Buy	141,720 +74,584	+111%	+$6.24M	0.15%	156
2023 Q1	$5.12M	Sell	67,136 -4,671	-7%	-$388K	0.06%	269
2022 Q4	$5.86M	Buy	71,807 +24,401	+51%	+$1.98M	0.09%	240
2022 Q3	$3.85M	Sell	47,406 -18,840	-28%	-$1.59M	0.06%	264
2022 Q2	$4.94M	Buy	66,246 +45,025	+212%	+$3.38M	0.07%	241
2022 Q1	$1.94M	Buy	21,221 +6,552	+45%	+$605K	0.03%	400
2021 Q4	$1.67M	Buy	14,669 +8,749	+148%	+$1.06M	0.02%	490
2021 Q3	$747K	Buy	5,920 +3,550	+150%	+$457K	0.01%	549
2021 Q2	$323K	Sell	2,370 -15,868	-87%	-$2.09M	0.01%	698
2021 Q1	$2.44M	Buy	18,238 +7,575	+71%	+$1.13M	0.05%	306
2020 Q4	$1.5M	Buy	+10,663	New	+$1.37M	0.04%	390
2020 Q3	–	Sell	-1,801	Closed	-$201K	–	762
2020 Q2	$201K	Sell	1,801 -3,358	-65%	-$331K	0.01%	712
2020 Q1	$399K	Buy	5,159 +966	+23%	+$85.5K	0.01%	527
2019 Q4	$398K	Buy	+4,193	New	+$363K	0.01%	566

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's XBI Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria increased its State Street SPDR S&P Biotech ETF (XBI) stake by 156% in Q1 2026, buying an estimated $8.11M and bringing the position to 106,595 shares worth $13.4M. The position accounts for 0.09% of the portfolio, ranked #154.

Banco Bilbao Vizcaya Argentaria first reported a position in XBI in Q4 2019 and has held it in 24 quarters since. 815 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Banco Bilbao Vizcaya Argentaria held 106,595 shares of State Street SPDR S&P Biotech ETF worth $13.4M as of Q1 2026.
Banco Bilbao Vizcaya Argentaria bought 64,928 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $8.11M.
State Street SPDR S&P Biotech ETF made up 0.09% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #154 holding.
Banco Bilbao Vizcaya Argentaria first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 24 quarters since.
815 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.